Review
doi: 10.1016/j.jhep.2018.03.019.
Epub 2018 Apr 5.
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Collaborators
- PMID: 29628281
- DOI: 10.1016/j.jhep.2018.03.019
Item in Clipboard
Review
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
J Hepatol.
2018 Jul.
Erratum in
-
Corrigendum to "EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma" [J Hepatol 69 (2018) 182-236].J Hepatol. 2019 Apr;70(4):817. doi: 10.1016/j.jhep.2019.01.020. Epub 2019 Feb 7. J Hepatol. 2019. PMID: 30739718 No abstract available.
No abstract available
Similar articles
-
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease.J Hepatol. 2018 Jul;69(1):154-181. doi: 10.1016/j.jhep.2018.03.018. Epub 2018 Apr 5. J Hepatol. 2018. PMID: 29628280 Review. No abstract available.
-
Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version.Dig Dis. 2011;29(3):339-64. doi: 10.1159/000327577. Epub 2011 Aug 9. Dig Dis. 2011. PMID: 21829027
-
World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.J Gastrointestin Liver Dis. 2010 Sep;19(3):311-7. J Gastrointestin Liver Dis. 2010. PMID: 20922197 No abstract available.
-
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan.J Formos Med Assoc. 2018 May;117(5):381-403. doi: 10.1016/j.jfma.2017.09.007. Epub 2017 Oct 24. J Formos Med Assoc. 2018. PMID: 29074347
-
Current Guidelines for the Diagnosis and Management of Hepatocellular Carcinoma: A Comparative Review.AJR Am J Roentgenol. 2016 Nov;207(5):W88-W98. doi: 10.2214/AJR.15.15490. Epub 2016 Aug 4. AJR Am J Roentgenol. 2016. PMID: 27490855 Review.
Cited by
-
Predictors of Immediate Deterioration of the Child-Pugh Classification From A to B After Transcatheter Arterial Chemo-Embolization for Treatment-Naive Hepatocellular Carcinoma.Cancer Med. 2024 Nov;13(21):e70367. doi: 10.1002/cam4.70367. Cancer Med. 2024. PMID: 39487694 Free PMC article.
-
Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines.Insights Imaging. 2024 Oct 31;15(1):263. doi: 10.1186/s13244-024-01838-x. Insights Imaging. 2024. PMID: 39480596 Free PMC article.
-
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?J Hepatol. 2023 Jan;78(1):207-216. doi: 10.1016/j.jhep.2022.08.036. Epub 2022 Sep 8. J Hepatol. 2023. PMID: 36089157 Free PMC article. Review.
-
CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenib.Eur Radiol. 2021 Mar;31(3):1608-1619. doi: 10.1007/s00330-020-07171-3. Epub 2020 Aug 22. Eur Radiol. 2021. PMID: 32827266 Free PMC article.
-
Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.Clin Mol Hepatol. 2022 Oct;28(4):851-863. doi: 10.3350/cmh.2022.0037. Epub 2022 Jun 3. Clin Mol Hepatol. 2022. PMID: 36263667 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
